Prospects and Challenges in the Development of Universal Influenza Vaccines by Anders Madsen, Rebecca Jane Cox

Subjects: Get full text

<i>Lactobacillus acidophilus</i> Expressing Murine Rotavirus VP8 and Mucosal Adjuvants Induce Virus-Specific Immune Responses by Darby Gilfillan, Allison C. Vilander, Meichen Pan, Yong Jun Goh, Sarah O’Flaherty, Ningguo Feng, Bridget E. Fox, Callie Lang, Harry B. Greenberg, Zaid Abdo, Rodolphe Barrangou, Gregg A. Dean

Subjects: Get full text

Vaccine Development Against Tuberculosis Over the Last 140 Years: Failure as Part of Success by Stefan H. E. Kaufmann, Stefan H. E. Kaufmann, Stefan H. E. Kaufmann

Subjects: Get full text

Tackling suppressive cancer microenvironment by NARF-derived immune modulatory vaccine and its validation using simulation strategies by Priyanga Paranthaman, Shanthi Veerappapillai

Subjects: Get full text

New Vaccine Platforms—Novel Dimensions of Economic and Societal Value and Their Measurement by Philip O. Buck, Dumingu Aparna Gomes, Ekkehard Beck, Noam Kirson, Matthew Mattera, Stuart Carroll, Bernhard Ultsch, Kavisha Jayasundara, Mathieu Uhart, Louis P. Garrison, Jr.

Subjects: Get full text

Immunoinformatics-Based Proteome Mining to Develop a Next-Generation Vaccine Design against <i>Borrelia burgdorferi</i>: The Cause of Lyme Borreliosis by Kashaf Khalid, Omar Ahsan, Tanwir Khaliq, Khalid Muhammad, Yasir Waheed

Subjects: Get full text

Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development by Melinda Ahmels, Filipe C. Mariz, Ilona Braspenning-Wesch, Sonja Stephan, Bettina Huber, Gabriele Schmidt, Rui Cao, Martin Müller, Reinhard Kirnbauer, Frank Rösl, Daniel Hasche

Subjects: Get full text

Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines by Naomi R. Waterlow, Simon R. Procter, Rosalind M. Eggo, Mark Jit

Subjects: Get full text

Importance of adjuvant selection in tuberculosis vaccine development: Exploring basic mechanisms and clinical implications by Han Gyu Choi, Kee Woong Kwon, Sung Jae Shin

Subjects: Get full text

Potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study by Naomi R. Waterlow, Sreejith Radhakrishnan, Jeanette Dawa, Edwin van Leeuwen, Simon R. Procter, Philipp Lambach, Joseph Bresee, Marie Mazur, Rosalind M. Eggo, Mark Jit

Subjects: Get full text

Vibrio cholerae, classification, pathogenesis, immune response, and trends in vaccine development by David A. Montero, Roberto M. Vidal, Roberto M. Vidal, Juliana Velasco, Juliana Velasco, Sergio George, Yalda Lucero, Yalda Lucero, Leonardo A. Gómez, Leandro J. Carreño, Leandro J. Carreño, Richard García-Betancourt, Miguel O’Ryan

Subjects: Get full text

Editorial: Novel Vaccine Technologies in Animal Health by Vasilis C. Pliasas, George C. Fthenakis, Constantinos S. Kyriakis, Constantinos S. Kyriakis

Subjects: Get full text

New Points of Departure for More Global Influenza Vaccine Use by Irina Kiseleva

Subjects: Get full text

Trained Immunity as a Prospective Tool against Emerging Respiratory Pathogens by John Joseph

Subjects: Get full text

Next-generation treatments: Immunotherapy and advanced therapies for COVID-19 by Jenny Andrea Arevalo-Romero, Sandra M. Chingaté-López, Bernardo Armando Camacho, Carlos Javier Alméciga-Díaz, Cesar A. Ramirez-Segura

Subjects: “…Next-generation vaccines…”
Get full text

Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines by Gerardo Montalvo Zurbia-Flores, Christine S Rollier, Arturo Reyes-Sandoval

Subjects: “…yellow fever next-generation vaccines…”
Get full text

A rational strategy for the maintenance of antiviral immunity to new SARS-CoV-2 strains by Vladimir P. Baklaushev, Gaukhar M. Yusubalieva, Mikhail V. Bychinin, Saule M. Yusubalieva, Vladimir A. Kalsin, Aleksandr V. Troitskiy

Subjects: Get full text